证券代码：002690 证券简称：美亚光电 公告编号：2025-015 合肥美亚光电技术股份有限公司 第五届董事会第十四次会议决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、误导性 陈述或者重大遗漏。 合肥美亚光电技术股份有限公司董事会 1、审议通过《关于投资建设智能化涂装钣金生产基地扩产项目的议案》 表决结果：5 票同意，0 票反对，0 票弃权。 公司拟投资 1.85 亿元建设智能化涂装钣金生产基地扩产项目。该项目建成后，将新 增涂装、钣金、机加工产能 1 万台套/年，为公司未来发展提供有效的产能支撑。具体情 况请见 2025 年 6 月 5 日刊登在《证券时报》、巨潮资讯网（http://www.cninfo.com.cn） 上的《关于投资建设智能化涂装钣金生产基地扩产项目的公告》。 三、备查文件 1、经与会董事签字并加盖董事会印章的第五届董事会第十四次会议决议； 2、深交所要求的其他文件。 一、董事会会议召开情况 合肥美亚光电技术股份有限公司（以下简称"公司"）于 2025 年 5 月 30 日以电话或 电子邮件的方式发出召开第五届董事会第十四次会议的通知，会议于 2025 ...

Core Viewpoint - The company Meiya Optoelectronics (002690) plans to invest 185 million yuan in the construction of an intelligent coating and sheet metal production base expansion project, expected to gradually commence production in the first half of 2027 [1] Investment Project Summary - The project will add a production capacity of 10,000 sets per year for coating, sheet metal, and machining [1] - The investment will be funded by the company's own resources, indicating a strong operational status and sufficient funds [1] - The project is not expected to adversely affect the company's financial and operational conditions, nor harm the interests of the company and all shareholders [1]

Industry Overview - The dental medical equipment industry is experiencing rapid growth in China, driven by an aging population and increasing disposable income, leading to heightened awareness of oral health [1][8] - The market size for dental medical equipment in China is projected to grow from 22.3 billion yuan in 2020 to 41.2 billion yuan in 2024, with a compound annual growth rate (CAGR) of 16.59% [1][8] - The global dental medical equipment market is also expanding, expected to increase from 14.6 billion USD in 2020 to 20.7 billion USD in 2024, with a CAGR of 9.12% [6] Market Dynamics - The demand for dental medical services is rising, leading to a robust growth phase for the dental equipment market in China [1][8] - The domestic market for dental medical equipment is forecasted to reach 47.9 billion yuan by 2025 [1][8] - The domestic CBCT (Cone Beam Computed Tomography) market is becoming a focal point, with the localization rate expected to rise from 16.3% in 2020 to 56.44% in 2024 [10][18] Competitive Landscape - Major players in the Chinese dental medical equipment market include Xinhua Medical, Meiya Optoelectronics, Times Angel, and Kangzhong Medical [2][12] - The industry is currently reliant on imports for 90% of its dental equipment, particularly in the mid-to-high-end segments, but there is a significant opportunity for domestic companies to replace imports [12][18] - Key products from leading companies include CBCT systems, dental sterilization equipment, and implant devices [14][16] Development Trends - There is a notable acceleration in domestic replacement and technological breakthroughs, particularly in CBCT, with expectations for further advancements in high-end sectors [18] - The integration of digital and intelligent technologies is transforming the dental medical equipment industry, enhancing diagnostic efficiency and patient experience [19] - The market is witnessing a segmentation in demand, with older populations driving the need for dental implants and younger consumers pushing for aesthetic treatments like invisible orthodontics [20]

Core Insights - The CT equipment market in China is projected to reach approximately 25.5 billion yuan in 2024, driven by increasing clinical demand due to an aging population and rising chronic disease prevalence [1][20] - The market is expected to maintain rapid growth as investments in healthcare increase and the implementation of hierarchical medical care continues [1][20] Industry Overview - CT, or computed tomography, is a medical imaging technology that utilizes X-rays to create detailed images of the body's internal structures, widely used for diagnosing various diseases [3][7] - The CT equipment industry is characterized by high technical barriers, requiring long-term technological accumulation for both core component development and complete device manufacturing [16] Market Dynamics - The demand for CT equipment is increasing due to the aging population and the growing need for medical examinations, with the number of CT devices in China expected to reach approximately 55,133 units by 2024 [21] - The domestic CT equipment market's localization rate is projected to be around 53% in 2024, with over 66% of sales coming from high-quality domestic brands [23] Competitive Landscape - The CT equipment industry in China exhibits a tiered competitive structure, with leading companies like GE Healthcare, United Imaging, and Siemens dominating the high-end market, while domestic firms are rapidly catching up through technological innovation [26][28] - Companies such as United Imaging and Wandong Medical are focusing on high-performance imaging equipment and innovative solutions to enhance their market presence [28][30] Policy Environment - The Chinese government has implemented strict regulatory frameworks for medical devices, promoting high-quality development and technological innovation in the CT equipment sector [9][11] - Recent policies aim to enhance the regulatory system for medical devices, ensuring safety and effectiveness while fostering innovation and competitiveness in the industry [9][11] Future Trends - The industry is witnessing a shift towards technological innovation and domestic substitution, with local manufacturers making significant strides in core component production and image quality [32] - The demand for CT equipment in grassroots medical institutions is expected to grow, driven by the hierarchical medical care policy and the increasing number of private hospitals [33] - The integration of AI and digital technologies in CT equipment is anticipated to enhance diagnostic capabilities and operational efficiency, aligning with the industry's move towards sustainability and environmental compliance [34]

1、公司 2024 年度权益分派方案为：以截至 2024 年 12 月 31 日公司股份总 数 882,257,450 股为基数，向全体股东按每 10 股派发现金股利人民币 7.00 元（含 税），合计派发现金股利 617,580,215.00 元，剩余未分配利润结转以后年度分配， 不送红股，不以资本公积金转增股本。 2、公司股本总额自分配方案披露至实施期间未发生变化；若公司股本总额 在权益分派实施前发生变化，公司将按照分配比例不变的原则对分配总额进行调 整。 3、本次实施的分配方案与公司 2024 年年度股东大会审议通过的分配方案及 其调整原则一致。 4、本次实施分配方案距离股东大会审议通过的时间未超过两个月。 证券代码：002690 证券简称：美亚光电 公告编号：2025-014 合肥美亚光电技术股份有限公司 2024 年年度权益分派实施公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 合肥美亚光电技术股份有限公司（以下简称"公司"）2024 年度利润分配方 案已获 2025 年 4 月 22 日召开的 2024 年年度股东大会审议通过，现将权益分派 ...

Financial Performance - The company's revenue for Q1 2025 reached ¥392,340,157.04, representing an increase of 18.39% compared to ¥331,400,004.80 in the same period last year[5] - Net profit attributable to shareholders was ¥108,455,126.71, up 7.49% from ¥100,900,473.07 year-on-year[5] - Total operating revenue for the current period reached ¥392,340,157.04, an increase of 18.4% compared to ¥331,400,004.80 in the previous period[20] - Net profit for the current period was ¥108,455,126.71, representing a growth of 7.5% from ¥100,900,473.07 in the previous period[21] - The total comprehensive income for the current period was ¥115,208,159.49, compared to ¥77,751,141.83 in the prior period, an increase of 48.2%[21] Cash Flow - The net cash flow from operating activities improved significantly to ¥57,178,541.55, a 201.09% increase from a negative cash flow of -¥56,559,795.05 in the previous year[5] - The company reported a significant increase in cash received from operating activities, totaling ¥45,637,105.47, which is 168.50% higher than ¥16,997,217.60 in the previous year[10] - Operating cash flow generated a net amount of ¥57,178,541.55, a significant improvement from a negative ¥56,559,795.05 in the previous period[24] - Cash inflow from operating activities totaled ¥539,111,932.11, compared to ¥416,779,029.20 in the prior year, reflecting a year-over-year increase of approximately 29.3%[24] - Cash outflow from operating activities was ¥481,933,390.56, slightly up from ¥473,338,824.25, indicating a marginal increase of about 1.2%[24] Assets and Liabilities - Total assets at the end of Q1 2025 were ¥3,415,577,397.86, reflecting a 2.33% increase from ¥3,337,783,990.61 at the end of the previous year[5] - The total liabilities decreased to ¥481,199,522.76 from ¥549,779,197.80, a reduction of 12.4%[19] - The total equity attributable to shareholders rose to ¥2,934,377,875.10, up from ¥2,788,004,792.81, an increase of 5.2%[19] Shareholder Information - Total number of common shareholders at the end of the reporting period is 33,768[14] - The largest shareholder, Tian Ming, holds 60.92% of shares, totaling 537,462,900 shares[14] - The top 10 shareholders hold a significant portion of shares, with the top three accounting for over 67%[14] Expenses - The company's sales expenses increased by 33.81% to ¥44,719,236.90, primarily due to higher sales revenue[11] - Research and development expenses increased to ¥29,037,017.55, compared to ¥24,970,715.89 in the previous period, marking an increase of 16.4%[20] Cash and Cash Equivalents - Cash and cash equivalents decreased to ¥1,474,464,320.36 from ¥1,560,367,800.56[18] - The net increase in cash and cash equivalents was ¥36,818,839.24, down from ¥144,322,343.70 in the previous period[25] - The ending balance of cash and cash equivalents stood at ¥1,445,303,209.01, compared to ¥1,530,116,625.88 at the end of the previous year[25] Other Financial Metrics - The company's basic earnings per share rose to ¥0.1230, marking a 7.33% increase from ¥0.1146 in the same quarter last year[5] - The weighted average return on equity increased to 3.81%, up from 3.60% year-on-year[5] - Other comprehensive income after tax was ¥6,753,032.78, a significant recovery from a loss of ¥23,149,331.24 in the previous period[21] - The company reported a financial income of ¥10,586,561.44, down from ¥13,480,580.77, a decrease of 21.5%[20] Investment Activities - Investment activities resulted in a net cash outflow of ¥21,411,581.45, contrasting with a net inflow of ¥190,257,241.15 in the previous year[24] - Cash inflow from investment activities was ¥301,647,684.54, up from ¥201,329,312.88, marking a year-over-year increase of approximately 49.8%[24] - Cash outflow from investment activities surged to ¥323,059,265.99 from ¥11,072,071.73, indicating a significant increase in investment spending[24] Audit Status - The first quarter report was not audited, indicating that the financial figures are preliminary and subject to change[26]

证券代码：002690 证券简称：美亚光电 公告编号：2025-011 合肥美亚光电技术股份有限公司 2024年年度股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会未出现否决议案的情形； 2、本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 合肥美亚光电技术股份有限公司（以下简称"公司"）董事会于2025年03月 28日在《证券时报》、巨潮资讯网（http://www.cninfo.com.cn）上刊登了《关 于召开2024年年度股东大会的通知》。 （2）现场会议召开地点：合肥市高新技术产业开发区望江西路668号公司会 议室 （3）股权登记日：2025年4月15日 （4）会议召开方式：本次股东大会采用现场表决与网络投票相结合的方式 召开。 1、会议召开情况 （1）会议召开时间 现场会议时间：2025年4月22日下午14:30 网络投票时间： 通过深圳证券交易所交易系统进行网络投票的具体时间为2025年4月22日上 午9:15—9:25、9:30－11:30和下午13:00－15:00。 通过 ...

证券代码：002690 证券简称：美亚光电 公告编号：2025-012 合肥美亚光电技术股份有限公司 关于回购注销部分已授予限制性股票减资 暨通知债权人的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏。 合肥美亚光电技术股份有限公司（以下简称"公司"）第五届董事会第十 二次会议、第五届监事会第十一次会议以及2024年年度股东大会，分别审议通 过了《关于回购注销部分限制性股票的议案》。 鉴于首次及预留授予的激励对象中共有6名激励对象已离职，其中，首次授 予部分激励对象离职人数2名，预留授予部分激励对象离职人数6名（本次首次 授予及预留授予离职激励对象部分重合），上述离职人员不再具备激励对象资 格，根据《公司2021年限制性股票激励计划（草案）》及相关法律、法规的规 定，公司决定对其已获授但尚未解除限售的22,400股限制性股票进行回购注 销。 本次回购注销已授予但尚未解除限售的制性股票总计22,400股，占公司总 股本882,257,450股的比例为0.0025%。本次回购注销完成后，公司总股本将由 882,257,450股减少至882,235,050股。 公司 ...

法律意见书 安徽天禾律师事务所 关于合肥美亚光电技术股份有限公司 2024 年年度股东大会的法律意见书 - 1 - 法律意见书 年 4 月 22 日上午 9:15～9:25、9:30～11:30 和下午 13:00～15:00；通过深圳证券 交易所互联网投票系统投票的具体时间为 2025 年 4 月 22 日上午 9:15 至下午 15:00。本次股东大会召开的实际时间、地点、方式、会议审议的议案与会议通知 内容一致。 天律意 2025 第 00805 号 致：合肥美亚光电技术股份有限公司 根据《中华人民共和国公司法》(下称"《公司法》")、《中华人民共和 国证券法》（下称"《证券法》"）、《上市公司股东会规则》和《合肥美亚 光电技术股份有限公司章程》（下称"《公司章程》"）的有关规定，安徽天 禾律师事务所接受合肥美亚光电技术股份有限公司（下称"公司"）的委托， 指派本所李军、陈策律师出席公司 2024 年年度股东大会（下称"本次股东大 会"），并对本次股东大会相关事项进行见证，出具法律意见。 本所同意将本法律意见书作为本次股东大会的公告文件，随公司其他文件一 并报送有关主管部门审查并予以公告。 本所根据《证 ...

合肥美亚光电技术股份有限公司 章程 二〇二五年四月 目 录 第一章 总则 第二章 经营宗旨和范围 第三章 股份 第一节 股份发行 第二节 股份增减和回购 第三节 股份转让 第四章 股东和股东大会 第一节 股东 第二节 股东大会的一般规定 第三节 股东大会的召集 第四节 股东大会的提案与通知 第五节 股东大会的召开 第六节 股东大会的表决和决议 第五章 董事会 第一节 董事 第二节 董事会 第六章 总经理及其他高级管理人员 第七章 监事会 第一节 监事 第二节 监事会 第八章 财务会计制度、利润分配和审计 第一节 财务会计制度 第二节 内部审计 第三节 会计师事务所的聘任 第九章 通知与公告 第一节 通知 第二节 公告 第十章 合并、分立、增资、减资、解散和清算 第一节 合并、分立、增资和减资 第二节 解散和清算 第十一章 修改章程 第十二章 附则 第一章 总则 第一条 为维护合肥美亚光电技术股份有限公司（以下简称"公司"）、股东 和债权人的合法权益，规范公司的组织和行为，根据《中华人民共和国公司法》 （以下简称《公司法》）、《中华人民共和国证券法》（以下简称《证券法》）和 其他有关规定，制订本章程。 第二条 ...